Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorMorrison, P J
dc.contributor.authorSteel, C M
dc.contributor.authorVasen, H F A
dc.contributor.authorEccles, D
dc.contributor.authorEvans, D G R
dc.contributor.authorMoller, P
dc.contributor.authorHodgson, S
dc.contributor.authorStoppa-Lyonnet, D
dc.contributor.authorChang-Claude, J
dc.contributor.authorCaligo, M
dc.contributor.authorOlah, E
dc.contributor.authorHaites, N E
dc.contributor.authorNevin, N C
dc.date.accessioned2014-05-07T16:01:01Z
dc.date.available2014-05-07T16:01:01Z
dc.date.issued1999-10
dc.identifier.citationMorrison , P J , Steel , C M , Vasen , H F A , Eccles , D , Evans , D G R , Moller , P , Hodgson , S , Stoppa-Lyonnet , D , Chang-Claude , J , Caligo , M , Olah , E , Haites , N E & Nevin , N C 1999 , ' Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe ' , Disease Markers , vol. 15 , pp. 159-165 . https://doi.org/10.1155/1999/748254en
dc.identifier.issn1875-8630
dc.identifier.otherPURE: 833316
dc.identifier.otherPURE UUID: 76c20587-fd7f-483c-a921-0d9127f01204
dc.identifier.otherWOS: 000083988300056
dc.identifier.otherScopus: 0032710960
dc.identifier.urihttps://hdl.handle.net/10023/4721
dc.descriptionThis work was supported by a Biomed demonstration project grant number BMH4- CT96-1133.en
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofDisease Markersen
dc.rightsCopyright © 1999 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectInsuranceen
dc.subjectGenetic testingen
dc.subjectEuropeen
dc.subjectGuidelinesen
dc.subjectBreast & ovarian canceren
dc.subjectFamilyen
dc.subjectGeneen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccRC0254en
dc.titleInsurance implications for individuals with a high risk of breast and ovarian cancer in Europeen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.identifier.doihttps://doi.org/10.1155/1999/748254
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record